Wang Yong-qing, Fan Xun-mei, Zhou Tao, Qi Yu-jie, Chen Hui, Qian Su-yun
Department of Pediatric Intensive Care Unit, Beijing Children's Hospital, Capital University of Medical Sciences, Beijing 100045, China.
Zhonghua Er Ke Za Zhi. 2006 Feb;44(2):131-5.
Severe sepsis and septic shock remain the most common cause of death in intensive care units. The main causes of death in sepsis are the cardiac dysfunction and hypotension resistant to cateolamines. The prevalence of relative adrenal insufficiency in severe sepsis and septic shock was estimated at about 32%-51%. Several meta-analysis demonstrated that high-dose glucocorticoids decreased survival during sepsis, while stress doses of corticosteroids may benefit these patients. The exact reason for such widely divergent outcome produced by different doses of corticosteroid is still not understood. Therefore, the study was undertaken to observe the effects of different doses of hydrocortisone (HC) on circulating and intramyocardial inflammatory mediators in severe septic rats with myocardial injury induced by Escherichia coli (E. coli).
The model was established by two injections of inactivated E. coli Forty male Wistar rats were randomly divided into five groups: high-dose of HC group (150 mg/kg), medium-dose group (20 mg/kg), low-dose group (6 mg/kg), model group (NS substituted for HC), and control group (NS for E. coli and HC). Each group had eight rats. After 2 hours of treatment, specimens were collected to measure serum cardiac troponin I (cTnI), tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), nitric oxide (NO) and total NO synthase (NOS). NO and total NOS in myocardial homogenate were also detected. The expression of inducible NOS (iNOS) of myocytes was investigated.
All the above-mentioned markers in model group significantly higher than those in control group. After HC injection, serum cTnI concentrations in low-dose group decreased to normal values compared to that of model group, while in another two HC groups, the concentrations were higher than those in model group. TNF-alpha level was not significantly influenced. But IL-1beta level declined to normal values, being prominent in low-dose HC group. Neither high-dose nor middle-dose HC could lower serum NO or total NOS, but low-dose HC could greatly inhibit both NO and NOS levels (P < 0.05). There was no significant difference in the level of NO and total NOS of myocardial homogenate between left and right ventricles. There was no iNOS expression by normal myocardium, while the expression in model group was significantly increased. After HC injection, the iNOS expressions by myocardium in three HC groups were weaker than those in model group. The intensity of iNOS signals became weak with the decrease in HC dose.
Different doses of HC might exert different effects on circulating and intramyocardial inflammatory mediators in severely septic rats with myocardial injury induced by E. coli. Low-dose HC could significantly inhibit such mediators as well as iNOS expression by cardiomyocytes. The results suggest that low dose HC exert protective effect on myocardial injury of severely septic rats.
严重脓毒症和脓毒性休克仍然是重症监护病房最常见的死亡原因。脓毒症的主要死亡原因是心功能障碍和对儿茶酚胺抵抗的低血压。严重脓毒症和脓毒性休克中相对肾上腺皮质功能不全的患病率估计约为32%-51%。多项荟萃分析表明,大剂量糖皮质激素会降低脓毒症期间的生存率,而应激剂量的皮质类固醇可能使这些患者受益。不同剂量皮质类固醇产生如此大相径庭结果的确切原因仍不清楚。因此,本研究旨在观察不同剂量氢化可的松(HC)对由大肠杆菌(E. coli)诱导心肌损伤的严重脓毒症大鼠循环和心肌内炎症介质的影响。
通过两次注射灭活的大肠杆菌建立模型。40只雄性Wistar大鼠随机分为五组:高剂量HC组(150 mg/kg)、中剂量组(20 mg/kg)、低剂量组(6 mg/kg)、模型组(用生理盐水替代HC)和对照组(用生理盐水替代大肠杆菌和HC)。每组8只大鼠。治疗2小时后,采集标本测量血清心肌肌钙蛋白I(cTnI)、肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、一氧化氮(NO)和总一氧化氮合酶(NOS)。还检测心肌匀浆中的NO和总NOS。研究心肌细胞诱导型NOS(iNOS)的表达。
模型组上述所有指标均显著高于对照组。注射HC后,低剂量组血清cTnI浓度与模型组相比降至正常水平,而另外两个HC组的浓度高于模型组。TNF-α水平未受显著影响。但IL-1β水平降至正常水平,在低剂量HC组中尤为明显。高剂量和中剂量HC均不能降低血清NO或总NOS,但低剂量HC能显著抑制NO和NOS水平(P < 0.05)。左右心室心肌匀浆中NO和总NOS水平无显著差异。正常心肌无iNOS表达,而模型组表达显著增加。注射HC后,三个HC组心肌中的iNOS表达均弱于模型组。iNOS信号强度随HC剂量降低而减弱。
不同剂量的HC可能对由大肠杆菌诱导心肌损伤的严重脓毒症大鼠循环和心肌内炎症介质产生不同影响。低剂量HC能显著抑制此类介质以及心肌细胞的iNOS表达。结果表明低剂量HC对严重脓毒症大鼠的心肌损伤具有保护作用。